⌘K
t
Kanabo Group Plc announced that on June 19, 2023, it granted options over a total of 25,050,000 ordinary shares to certain employees and persons discharging managerial responsibilities (PDMRs) at an exercise price of 2.88p per share. These options were granted to individuals including David Tsur, Ian Mattioli, Sharon Malka, Assaf Vardimon, and Suleman Sacranie. Concurrently, Suleman Sacranie agreed to surrender 5,829,400 previously granted options from August 31, 2022, which carried exercise prices of 6.5p and 8p.
| Date | 23 Jun 2023 |
| Time | 07:00:04 |
| Category | Miscellaneous |
| ID | 6602D |
23 June 2023
Kanabo Group Plc
("Kanabo" or the "Company")
Grant of Options
Kanabo Group Plc (LSE:KNB), the patient focused healthcare technology and medicinal cannabis company, announces that on 19 June 2023 it granted options over a total of 25,050,000 ordinary shares in the Company ("Shares") to certain employees, pursuant to their terms of employment (the "Awards").
The Awards were granted were granted to certain persons discharging managerial responsibilities ("PDMR") and other employees, and are summarised below:
|
Name |
No. of Options |
Vested options as of today |
Option Exercise Price |
Vesting Period for non-vested options |
|
David Tsur Deputy Chair |
2,000,000 |
- |
2.88p |
The options shall vest and become exercisable in twelve equal portions which shall vest over a 3-year period from the Vesting Start Date. |
|
Ian Mattioli Chair |
3,000,000 |
- |
2.88p |
The options shall vest and become exercisable in four equal portions which shall vest over a 2-year period from the Vesting Start Date |
|
Sharon Malka Non-Executive Director
|
2,025000 |
- |
2.88p |
The options shall vest and become exercisable in four equal portions which shall vest over a 2-year period from the Vesting Start Date. |
|
Assaf Vardimon CFO |
2,500,000 |
- |
2.88p |
The options shall vest and become exercisable in twelve equal portions which shall vest over a 3-year period from the Vesting Start Date. |
|
Suleman Sacranie CPO/CTO * |
11,000,000 |
5,500,004 |
2.88p |
The options shall vest and become exercisable in twelve equal portions which shall vest over a 3-year period from the Vesting Start Date. |
|
Other Employees |
2,500,000 |
- |
2.88p |
The options shall vest over a 3-year period. 33% vest at the end of the 12-month period following the Vesting Start Date. The remaining options vest over 8 equal 3-month periods thereafter. |
|
Other Employees |
2,025,000 |
- |
2.88p |
The options shall vest and become exercisable in twelve equal portions which shall vest over a 3-year period from the Vesting Start Date. |
* Mr. Sacranie has agreed to surrender 5,829,400 Options granted on 31 August 2022 which carry exercise price of 6.5p and 8p.
For further information, please visit http://www.kanabogroup.com/ or contact the following:
Enquiries:
|
Kanabo Group plc Avihu Tamir, Chief Executive Officer Assaf Vardimon, Chief Financial Officer
|
via Vigo Consulting +44 (0)20 7390 0230 |
|
Peterhouse Capital Ltd (Financial Adviser and Broker) Eran Zucker/ Lucy Williams / Charles Goodfellow
|
+44 (0)20 7469 0930 |
|
Vigo Consulting (Financial Public Relations/Investor Relations) Jeremy Garcia / Fiona Hetherington / Verity Snow kanabo@vigoconsulting.com |
+44 (0)20 7390 0230
|
About Kanabo Group Plc
Kanabo Group Plc (LSE:KNB) is a healthtech company committed to revolutionising patient care through its innovative technology platform and disruptive product offerings. Since its inception in 2017, Kanabo has been focused on researching, developing, and commercialising regulated medicinal cannabis-derived formulations and therapeutic inhalation devices.
Kanabo's NHS-approved online telehealth platform, The GP Service, provides patients with video consultations, online prescriptions, and primary care services. The Company is a leader in its field, focusing on improving patient outcomes and providing more accessible healthcare experiences.
In March 2023, Kanabo successfully launched its Pain Clinic, Treat It, under the expert guidance of its technological and product expertise. Treat It initially focuses on chronic pain management using plant-based medicine and treatments that are currently unavailable through traditional channels.
At Kanabo Group Plc, we are dedicated to providing patients with the highest quality medical treatments and more accessible healthcare experiences.
Visit www.kanabogroup.com for more information.
The Notification of Dealing Form provided in accordance with the requirements of the Market Abuse Regulation in relation to the transaction listed above is set out below.
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
||||
|
a)
|
Name
|
David Tsur
|
|||
|
2
|
Reason for the notification
|
||||
|
a)
|
Position/status
|
Non-Executive Director |
|||
|
b)
|
Initial notification /Amendment
|
Initial Notification |
|||
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
||||
|
a)
|
Name
|
Kanabo Group Plc |
|||
|
b)
|
LEI
|
213800XPJFSNWJIYKN52
|
|||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
||||
|
a)
|
Description of the financial instrument, type of instrument |
Ordinary Shares |
|||
|
|
|
||||
|
Identification code |
GB00BYQCS703 |
||||
|
|
|
||||
|
b)
|
Nature of the transaction
|
Share Options |
|||
|
c)
|
Price(s) and volume(s) |
|
|
|
|
|
|
|
Price(s) |
Volume(s) |
|
|
|
|
|
2.88p |
2,000,000 |
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
d)
|
Aggregated information |
|
|||
|
|
|
||||
|
- Aggregated volume |
N/A |
||||
|
|
|
||||
|
- Price |
N/A |
||||
|
|
|
||||
|
e)
|
Date of the transaction
|
19.6.2023 |
|||
|
f)
|
Place of the transaction
|
London Stock Exchange |
|||
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
||||
|
a)
|
Name
|
Ian Mattioli
|
|||
|
2
|
Reason for the notification
|
||||
|
a)
|
Position/status
|
Non-Executive Director |
|||
|
b)
|
Initial notification /Amendment
|
Initial Notification |
|||
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
||||
|
a)
|
Name
|
Kanabo Group Plc |
|||
|
b)
|
LEI
|
213800XPJFSNWJIYKN52
|
|||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
||||
|
a)
|
Description of the financial instrument, type of instrument |
Ordinary Shares |
|||
|
|
|
||||
|
Identification code |
GB00BYQCS703 |
||||
|
|
|
||||
|
b)
|
Nature of the transaction
|
Share Options |
|||
|
c)
|
Price(s) and volume(s) |
|
|
|
|
|
|
|
Price(s) |
Volume(s) |
|
|
|
|
|
2.88p |
3,000,000 |
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
d)
|
Aggregated information |
|
|||
|
|
|
||||
|
- Aggregated volume |
N/A |
||||
|
|
|
||||
|
- Price |
N/A |
||||
|
|
|
||||
|
e)
|
Date of the transaction
|
19.6.2023 |
|||
|
f)
|
Place of the transaction
|
London Stock Exchange |
|||
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
||||
|
a)
|
Name
|
Sharon Malka
|
|||
|
2
|
Reason for the notification
|
||||
|
a)
|
Position/status
|
Non-Executive Director |
|||
|
b)
|
Initial notification /Amendment
|
Initial Notification |
|||
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
||||
|
a)
|
Name
|
Kanabo Group Plc |
|||
|
b)
|
LEI
|
213800XPJFSNWJIYKN52
|
|||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
||||
|
a)
|
Description of the financial instrument, type of instrument |
Ordinary Shares |
|||
|
|
|
||||
|
Identification code |
GB00BYQCS703 |
||||
|
|
|
||||
|
b)
|
Nature of the transaction
|
Share Options |
|||
|
c)
|
Price(s) and volume(s) |
|
|
|
|
|
|
|
Price(s) |
Volume(s) |
|
|
|
|
|
2.88p |
2,025,000 |
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
d)
|
Aggregated information |
|
|||
|
|
|
||||
|
- Aggregated volume |
N/A |
||||
|
|
|
||||
|
- Price |
N/A |
||||
|
|
|
||||
|
e)
|
Date of the transaction
|
19.6.2023 |
|||
|
f)
|
Place of the transaction
|
London Stock Exchange |
|||
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
||||
|
a)
|
Name
|
Assaf Vardimon
|
|||
|
2
|
Reason for the notification
|
||||
|
a)
|
Position/status
|
CFO |
|||
|
b)
|
Initial notification /Amendment
|
Initial Notification |
|||
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
||||
|
a)
|
Name
|
Kanabo Group Plc |
|||
|
b)
|
LEI
|
213800XPJFSNWJIYKN52
|
|||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
||||
|
a)
|
Description of the financial instrument, type of instrument |
Ordinary Shares |
|||
|
|
|
||||
|
Identification code |
GB00BYQCS703 |
||||
|
|
|
||||
|
b)
|
Nature of the transaction
|
Share Options |
|||
|
c)
|
Price(s) and volume(s) |
|
|
|
|
|
|
|
Price(s) |
Volume(s) |
|
|
|
|
|
2.88p |
2,500,000 |
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
d)
|
Aggregated information |
|
|||
|
|
|
||||
|
- Aggregated volume |
N/A |
||||
|
|
|
||||
|
- Price |
N/A |
||||
|
|
|
||||
|
e)
|
Date of the transaction
|
19.6.2023 |
|||
|
f)
|
Place of the transaction
|
London Stock Exchange |
|||
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
||||
|
a)
|
Name
|
Suleman Sacranie |
|||
|
2
|
Reason for the notification
|
||||
|
a)
|
Position/status
|
CPO/CTO |
|||
|
b)
|
Initial notification /Amendment
|
Initial Notification |
|||
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
||||
|
a)
|
Name
|
Kanabo Group Plc |
|||
|
b)
|
LEI
|
213800XPJFSNWJIYKN52
|
|||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
||||
|
a)
|
Description of the financial instrument, type of instrument |
Ordinary Shares |
|||
|
|
|
||||
|
Identification code |
GB00BYQCS703 |
||||
|
|
|
||||
|
b)
|
Nature of the transaction
|
Share Options |
|||
|
c)
|
Price(s) and volume(s) |
|
|
|
|
|
|
|
Price(s) |
Volume(s) |
|
|
|
|
|
2.88p |
11,000,000 |
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
d)
|
Aggregated information |
|
|||
|
|
|
||||
|
- Aggregated volume |
N/A |
||||
|
|
|
||||
|
- Price |
N/A |
||||
|
|
|
||||
|
e)
|
Date of the transaction
|
19.6.2023 |
|||
|
f)
|
Place of the transaction
|
London Stock Exchange |
|||